Table 1.
Demographics and clinical characteristics of CD patients.
| Cohort [n] | 20 |
|---|---|
| Age /years old | 39.9 ± 13.43 |
| Sex [male/female] | 12/8 |
| BMI /kg·m−2 | 16.80 ± 2.20 |
| Smoker [n (%)] | 3 (15%) |
| Disease duration/months [range; median] | 3–204; 30 |
| Regions of disease involvement [n (%)] | |
| Isolated ileal | 5 (25%) |
| Ileocolonic | 15 (75%) |
| Colonic | 0 (0%) |
| Proximal small intestine or stomach or esophagus | 8 (40%) |
| Perianal disease | 10 (50%) |
| Stricture site | |
| Ileum only [n (%)] | 12 (60%) |
| Ileum + Colon [n (%)] | 8 (40%) |
| Length/cm [range; median] | 1.6–21.3; 5 |
| Smallest lumen circumference/cm [range; median] | 0–7; 1.85 |
| Bowel wall thickness/cm | 11.28 ± 4.28 |
| CDAI score | 132–500; 243.5 |
| History of bowel resection [n (%)] | 6 (30%) |
| Treatments in the preoperative time [n (%)] | |
| Mesalamine | 3 (15%) |
| Immunosuppressant | 7 (35%) |
| anti-TNFα agents | 8 (40%) |